Regentatlantic Capital LLC Elevance Health, Inc. Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Elevance Health, Inc. stock. As of the latest transaction made, Regentatlantic Capital LLC holds 44,315 shares of ELV stock, worth $16.2 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

44,315

Previous 45,041 1.61%

Holding current value

$16.2 Million

Previous $21.7 Million 7.39%

% of portfolio

0.6%

Previous 0.72%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$445.98 - $507.0 $323,781 - $368,082	-726 Reduced 1.61%	44,315 $20.1 Million
Q2 2022 Aug 15, 2022	SELL	$444.32 - $529.84 $833,100 - $993,450	-1,875 Reduced 4.0%	45,041 $21.7 Million
Q1 2022 May 02, 2022	SELL	$428.44 - $502.48 $478,995 - $561,772	-1,118 Reduced 2.33%	46,916 $23 Million
Q4 2021 Jan 27, 2022	SELL	$370.08 - $467.67 $272,008 - $343,737	-735 Reduced 1.51%	48,034 $22.3 Million
Q3 2021 Nov 15, 2021	SELL	$357.51 - $398.13 $518,389 - $577,288	-1,450 Reduced 2.89%	48,769 $18.2 Million
Q2 2021 Aug 12, 2021	SELL	$352.19 - $401.9 $203,213 - $231,896	-577 Reduced 1.14%	50,219 $19.2 Million
Q1 2021 Apr 29, 2021	SELL	$287.7 - $371.31 $488,514 - $630,484	-1,698 Reduced 3.23%	50,796 $18.2 Million
Q4 2020 Feb 04, 2021	SELL	$270.17 - $333.15 $947,756 - $1.17 Million	-3,508 Reduced 6.26%	52,494 $16.9 Million
Q3 2020 Oct 13, 2020	SELL	$245.73 - $284.63 $531,022 - $615,085	-2,161 Reduced 3.72%	56,002 $15 Million
Q2 2020 Aug 13, 2020	SELL	$203.3 - $300.59 $176,057 - $260,310	-866 Reduced 1.47%	58,163 $15.3 Million
Q1 2020 May 14, 2020	SELL	$174.68 - $307.74 $105,332 - $185,567	-603 Reduced 1.01%	59,029 $13.4 Million
Q4 2019 Feb 04, 2020	SELL	$234.82 - $306.42 $211,338 - $275,778	-900 Reduced 1.49%	59,632 $18 Million
Q3 2019 Oct 22, 2019	SELL	$237.69 - $310.48 $304,005 - $397,103	-1,279 Reduced 2.07%	60,532 $14.5 Million
Q2 2019 Jul 23, 2019	SELL	$236.25 - $293.76 $5,906 - $7,344	-25 Reduced 0.04%	61,811 $17.4 Million
Q1 2019 May 03, 2019	SELL	$248.42 - $317.42 $2.11 Million - $2.7 Million	-8,497 Reduced 12.08%	61,836 $17.7 Million
Q4 2018 Jan 30, 2019	SELL	$249.0 - $296.25 $427,782 - $508,957	-1,718 Reduced 2.38%	70,333 $18.5 Million
Q3 2018 Oct 30, 2018	SELL	$238.27 - $274.12 $350,256 - $402,956	-1,470 Reduced 2.0%	72,051 $19.7 Million
Q2 2018 Jul 31, 2018	BUY	$220.13 - $245.16 $81,888 - $91,199	372 Added 0.51%	73,521 $17.5 Million
Q1 2018 Apr 23, 2018	BUY	$215.63 - $258.19 $305,332 - $365,597	1,416 Added 1.97%	73,149 $16.1 Million
Q4 2017 Jan 23, 2018	SELL	$183.76 - $234.96 $112,644 - $144,030	-613 Reduced 0.85%	71,733 $16.1 Million
Q3 2017 Oct 25, 2017	BUY	$181.44 - $197.43 $13.1 Million - $14.3 Million	72,346	72,346 $13.7 Million

Others Institutions Holding ELV

# of Institutions

1,861

Shares Held

197M

Call Options Held

1.03M

Put Options Held

1.24M

View Full List

About Elevance Health, Inc.

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $87.8B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

More about ELV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Elevance Health, Inc. Transaction History